CRISPR Therapeutics AGCRSP
Market cap
$4.8B
P/E ratio
| 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Return on Assets | 0.1 | -12.5 | 8.6 | -7.4 | 16.5 | -26 | -6.9 | -16.4 |
| Return on equity (%) |
| 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Return on Assets | 0.1 | -12.5 | 8.6 | -7.4 | 16.5 | -26 | -6.9 | -16.4 |
| Return on equity (%) |